Gilead agrees to buy YM BioSciences for $510 million
Gilead Sciences Inc. has agreed to buy YM BioSciences Inc. for $510 million in cash, as the drug company looks to boost its oncology portfolio.
AP , 05.17.11, 05:46 PM EDT Irish biopharmaceutical company Shire PLC said Tuesday that it is buying Advanced BioHealing Inc. for $750 million.